drugset / Trial / NCT04072341

Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.

NCT04072341

RandomizedSequentialOpen-labelTreatment

Summary

End-stage chronic kidney disease is associated with the condition of chronic inflammation. Patients on hemodialysis are known to be predisposed to several factors that predispose to inflammation: dialysis membranes, central venous catheters, oxidative stress, fluid overload, sodium overload, uraemic toxins. Propolis, a natural resin produced by bees from plant materials, has anti-inflammatory, immunomodulatory, and anti-oxidant properties. The aim of this study was to evaluate the impact of Brazilian green propolis extract on inflammation in hemodialysis patients.

Timeline

Start
2019-08-01
Primary completion
2019-12-15
Completion
2020-01-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PROPOLIS WAX Traditional medicine (herbal / TCM) 250 mg